STEPHEN A. KLOTZ, M.D.; BILLY F. KAY, M.D.
To the editor: The following two case histories describe apparent adverse reactions to the histamine H2-receptor antagonist cimetidine (Tagamet®).
A 62-year-old woman with a complicated medical history that included an autoimmune thrombocytopenia (with antiplatelet antibodies) and arthritis and pleural effusion (with the absence of antinuclear antibodies, rheumatoid factor, or lupus erythematosus cell phenomenon) had been taking cimetidine, 300 mg four times daily for 1 month, for endoscopically proven severe antral gastritis and a bezoar. Concurrent medications included hydrochlorothiazide, 50 mg every day; propranolol, 20 mg three times daily; Synthroid®, 0.1 mg every day; and prednisone, 10 and 5 mg on
Learn more about subscription options.
Register Now for a free account.
KLOTZ SA, KAY BF. Cimetidine and Agranulocytosis. Ann Intern Med. 1978;88:579–580. doi: 10.7326/0003-4819-88-4-579_2
Download citation file:
Published: Ann Intern Med. 1978;88(4):579-580.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only